← Leaderboards
Robert J Hogan
Trudeau Institute, Inc.
$1,314,188
Attributed
$3,043,794
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $716.8K · FY2007–20$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$3,043,794 · 3
By mechanism
R01$2,594,409 · 1
R21$416,969 · 1
F32$32,416 · 1
Top collaborators
- Biao He6 shared
- Eric R Lafontaine6 shared
Most similar at Trudeau Institute, Inc.
Same institution · by research overlap
- David L Woodland$14,525,718
- Laura Haynes$9,283,662
- Kenneth H Ely$97,224
Others in their field
Top investigators on “Novel Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$450,123,047
- Barton F Haynes · Duke University$322,890,080
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$312,341,639
- Kiran Datta · Leidos Biomedical Research, Inc.$292,634,066
- Dennis R. Burton · Scripps Research Institute$274,644,614
- Sharon A Nachman · Johns Hopkins University$209,857,565
Research focus
Novel VaccinesVirusProteinsPathogenCell LineInfectionInfluenzaPathogenesisCellsCost EffectiveBacteriaBacteremiaAntibiotic TherapyChronicAdaptive Immune ResponseCoughingAerosolsBurkholderia InfectionsBurkholderiaAntigen TargetingBurkholderia MalleiBurkholderia PseudomalleiAcuteAdenoviruses
Grant awards (9)
A Novel Vaccine for Burkholderia pseudomallei and Burkholderia mallei$532,412
R01 · FY2020 · AI
A Novel Vaccine for Burkholderia pseudomallei and Burkholderia mallei$34,708
R01 · FY2020 · AI
A Novel Vaccine for Burkholderia pseudomallei and Burkholderia mallei$658,990
R01 · FY2019 · AI
A Novel Vaccine for Burkholderia pseudomallei and Burkholderia mallei$716,802
R01 · FY2018 · AI
A Novel Vaccine for Burkholderia pseudomallei and Burkholderia mallei$619,634
R01 · FY2017 · AI
A Novel Vaccine for Burkholderia pseudomallei and Burkholderia mallei$31,863
R01 · FY2017 · AI
Determining SARS-CoV host gene requirements by mutagenesis and RNA interface$180,872
R21 · FY2008 · AI · contact PI
Determining SARS-CoV host gene requirements by mutagenesis and RNA interface$236,097
R21 · FY2007 · AI · contact PI
T CELL IMMUNITY TO RESPIRATORY VIRUS INFECTIONS$32,416
F32 · FY2000 · AI